Tags

Type your tag names separated by a space and hit enter

Respiratory viruses and children.
J Infect. 2016 07 05; 72 Suppl:S29-33.JI

Abstract

Respiratory viruses place a great disease burden especially on the youngest children in terms of high rates of infection, bacterial complications and hospitalizations. In developing countries, some viral infections are even associated with substantial mortality in children. The interaction between viruses and bacteria is probably much more common and clinically significant than previously understood. Respiratory viruses frequently initiate the cascade of events that ultimately leads to bacterial infection. Effective antiviral agents can substantially shorten the duration of the viral illness and prevent the development of bacterial complications. Viral vaccines have the potential to not only prevent the viral infection but also decrease the incidence of bacterial complications. At present, antivirals and vaccines are only available against influenza viruses, but new vaccines and antivirals against other viruses, especially for RSV, are being developed.

Authors+Show Affiliations

Department of Pediatrics, University of Turku and Turku University Hospital, Kiinamyllynkatu 4-8, FI-20520 Turku, Finland. Electronic address: terho.heikkinen@utu.fi.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

27177731

Citation

Heikkinen, Terho. "Respiratory Viruses and Children." The Journal of Infection, vol. 72 Suppl, 2016, pp. S29-33.
Heikkinen T. Respiratory viruses and children. J Infect. 2016;72 Suppl:S29-33.
Heikkinen, T. (2016). Respiratory viruses and children. The Journal of Infection, 72 Suppl, S29-33. https://doi.org/10.1016/j.jinf.2016.04.019
Heikkinen T. Respiratory Viruses and Children. J Infect. 2016 07 5;72 Suppl:S29-33. PubMed PMID: 27177731.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Respiratory viruses and children. A1 - Heikkinen,Terho, Y1 - 2016/05/10/ PY - 2016/5/15/entrez PY - 2016/5/15/pubmed PY - 2017/7/29/medline KW - Antiviral KW - Bacteria KW - Influenza KW - Oseltamivir KW - Otitis media KW - Pneumonia KW - Respiratory syncytial virus KW - Vaccine KW - Virus SP - S29 EP - 33 JF - The Journal of infection JO - J Infect VL - 72 Suppl N2 - Respiratory viruses place a great disease burden especially on the youngest children in terms of high rates of infection, bacterial complications and hospitalizations. In developing countries, some viral infections are even associated with substantial mortality in children. The interaction between viruses and bacteria is probably much more common and clinically significant than previously understood. Respiratory viruses frequently initiate the cascade of events that ultimately leads to bacterial infection. Effective antiviral agents can substantially shorten the duration of the viral illness and prevent the development of bacterial complications. Viral vaccines have the potential to not only prevent the viral infection but also decrease the incidence of bacterial complications. At present, antivirals and vaccines are only available against influenza viruses, but new vaccines and antivirals against other viruses, especially for RSV, are being developed. SN - 1532-2742 UR - https://www.unboundmedicine.com/medline/citation/27177731/Respiratory_viruses_and_children_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0163-4453(16)30046-9 DB - PRIME DP - Unbound Medicine ER -